scispace - formally typeset
Open AccessJournal ArticleDOI

Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease

TLDR
This review summarizes the important cellular and molecular barrier components of the intestinal epithelium and emphasizes the mechanisms leading to barrier dysfunction during intestinal inflammation.
Abstract
The intestinal epithelium can be easily disrupted during gut inflammation as seen in inflammatory bowel disease (IBD), such as ulcerative colitis or Crohn's disease. For a long time, research into the pathophysiology of IBD has been focused on immune cell-mediated mechanisms. Recent evidence, however, suggests that the intestinal epithelium might play a major role in the development and perpetuation of IBD. It is now clear that IBD can be triggered by disturbances in epithelial barrier integrity via dysfunctions in intestinal epithelial cell-intrinsic molecular circuits that control the homeostasis, renewal, and repair of intestinal epithelial cells. The intestinal epithelium in the healthy individual represents a semi-permeable physical barrier shielding the interior of the body from invasions of pathogens on the one hand and allowing selective passage of nutrients on the other hand. However, the intestinal epithelium must be considered much more than a simple physical barrier. Instead, the epithelium is a highly dynamic tissue that responds to a plenitude of signals including the intestinal microbiota and signals from the immune system. This epithelial response to these signals regulates barrier function, the composition of the microbiota, and mucosal immune homeostasis within the lamina propria. The epithelium can thus be regarded as a translator between the microbiota and the immune system and aberrant signal transduction between the epithelium and adjacent immune cells might promote immune dysregulation in IBD. This review summarizes the important cellular and molecular barrier components of the intestinal epithelium and emphasizes the mechanisms leading to barrier dysfunction during intestinal inflammation.

read more

Citations
More filters
Journal ArticleDOI

Interaction between microbiota and immunity in health and disease

TL;DR: In this paper, the authors review features of microbiome-immunity crosstalk and their roles in health and disease, while providing examples of molecular mechanisms orchestrating these interactions in the intestine and extra-intestinal organs.
Journal ArticleDOI

Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development.

TL;DR: This review summarizes the current knowledge of the composition of the intestinal barrier and its assessment and modulation for the development of potential therapies for barrier dysfunction-associated diseases.
Journal ArticleDOI

Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.

TL;DR: The current studies suggest that altered barrier function may predispose or increase disease progression and therapies targeted to specifically restore the barrierfunction may provide a substitute or supplement to immunologic-based therapies.
Journal ArticleDOI

Prebiotics and Probiotics in Digestive Health.

TL;DR: While a considerable volume of basic science attests to the ability of various prebiotic molecules and probiotic strains to beneficially influence host immune responses, metabolic processes and neuro‐endocrine pathways, the evidence base from human studies leaves much to be desired.
Journal ArticleDOI

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut

TL;DR: This work genetically engineer E. coli Nissle 1917 to create a fibrous matrix that has a protective effect in DSS-induced colitis mice, and lays a foundation for the development of a platform in which the in situ production of therapeutic protein matrices from beneficial bacteria can be exploited.
References
More filters
Journal ArticleDOI

RELMβ/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract

TL;DR: It is demonstrated that a recently described intestinal goblet cell-specific protein, RELMbeta/FIZZ2, is induced after exposure to three phylogenetically distinct GI nematode pathogens, and it is suggested that intestinal goblingen cell-derived RELM beta may be a novel Th2 cytokine-induced immune-effector molecule in resistance to GI nem atode infection.
Journal ArticleDOI

Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier

TL;DR: Results show for the first time that occludin depletion in intestinal epithelial cells in vitro and in vivo leads to a selective or preferential increase in macromolecule flux, suggesting that occLudin plays a crucial role in the maintenance of TJ barrier through the large-channel TJ pathway, the pathway responsible for the macromolescule flux.
Journal ArticleDOI

Wnt signaling in adult intestinal stem cells and cancer.

TL;DR: The review summarizes recent advances in characterization of adult epithelial stem cells in the gut and presents novel experimental approaches utilized to investigate the epithelial cell signaling circuitry in vivo and in vitro.
Journal ArticleDOI

Is small intestinal permeability really increased in relatives of patients with Crohn's disease?

TL;DR: Intestinal permeability in relatives was similar to that in the control group, but a subpopulation had abnormally high permeability rates in the absence of clinical evidence for disease, concluding that the original hypothesis is still viable.
Related Papers (5)